| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/06/2013 | CN102917698A Dosage regimen of diaryl sulfide derivatives |
| 02/06/2013 | CN102911989A Lithium stimulation of cord blood stem cell proliferation and growth factor production |
| 02/06/2013 | CN102911987A Cells of which genome is modified |
| 02/06/2013 | CN102911831A Tonic grape wine |
| 02/06/2013 | CN102911812A Materia medica medicated soap composition and preparation method thereof |
| 02/06/2013 | CN102911279A Polysaccharide-peptide and liposome thereof |
| 02/06/2013 | CN102911260A Antagonists against interaction of PF4 and RANTES |
| 02/06/2013 | CN102911163A Quinazoline derivatives, composition containing derivatives and pharmaceutical application of derivatives |
| 02/06/2013 | CN102908614A Antioxidant health-care product containing SOD (Superoxide Dismutase) mixed with plant extract |
| 02/06/2013 | CN102908613A Porcine immuno-enhancer IL-12B (P40) and preparation method thereof |
| 02/06/2013 | CN102908610A Propolis combination used for livestock and preparation method of same |
| 02/06/2013 | CN102908608A Health care method for improving vaccine immunity effect and reducing immunity stress response of livestock and poultry |
| 02/06/2013 | CN102908590A Traditional Chinese medicine formula for resisting diseases, enhancing immunity and improving production performance of meat poultry |
| 02/06/2013 | CN102908512A Preparation method of red date and tuckahoe honeyed pills used for enhancing physical strength |
| 02/06/2013 | CN102908469A Traditional Chinese medicine for treating allergic rhinitis by using herba selaginellae doederleinii |
| 02/06/2013 | CN102908466A Propolis dropping pills and preparation method thereof |
| 02/06/2013 | CN102908459A Anti-fatigue healthcare product or pharmaceutical composition and preparation method and application thereof |
| 02/06/2013 | CN102908438A Kidney invigorating, essence strengthening, qi reinforcing, blood nourishing and body immunity improving capsules |
| 02/06/2013 | CN102908421A Chinese medicinal prescription for stag and preparation method thereof |
| 02/06/2013 | CN102908418A Traditional Chinese medicine for treating anaphylactic rhinitis |
| 02/06/2013 | CN102908390A Preparation method of Fructus Schisandrae/indigo honeysuckle oral liquid containing crude polysaccharides |
| 02/06/2013 | CN102908376A Extraction technology of phenolic substances in puna chicory |
| 02/06/2013 | CN102908369A Process for preparing shiitake extract |
| 02/06/2013 | CN102908366A Preparation method of chick embryo active component |
| 02/06/2013 | CN102908365A Preparation method of eggembryosin |
| 02/06/2013 | CN102908354A Preparation method of butafosfan injection |
| 02/06/2013 | CN102603627B Naphthlamide derivative used as protein kinase inhibitor and histone deacetylase inhibitor and preparation method of naphthlamide derivative |
| 02/06/2013 | CN102406664B Method for producing deer skin collagen |
| 02/06/2013 | CN102146074B Preparation method of pyrrole derivative and application thereof |
| 02/06/2013 | CN102133179B Stable cetirizine oral solution |
| 02/06/2013 | CN101584854B Romurtide cyclodextrin inclusion compound, preparation thereof and method for preparing same |
| 02/06/2013 | CN101549146B Romurtide injection and preparation method thereof |
| 02/06/2013 | CN101365338B Herbal powder extracts and methods of preparing and using the same |
| 02/06/2013 | CN101361864B Natural cordyceps sinensis oil |
| 02/06/2013 | CN101287487B Agents and methods based on the use of the EDA domain of fibronectin |
| 02/06/2013 | CN101142218B Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 02/05/2013 | US8367664 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors |
| 02/05/2013 | US8367623 Glycolipid and medicine for autoimmune disease containing the same as active ingredient |
| 02/05/2013 | US8367605 Copolymer-1 improvements in compositions of copolymers |
| 02/05/2013 | US8367071 Stimulant of immunology response |
| 02/05/2013 | CA2651597C Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease |
| 02/05/2013 | CA2511340C Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 02/05/2013 | CA2429636C Group 2 allergen specific ige-fabs and igg molecules and use thereof |
| 02/05/2013 | CA2320359C Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 01/31/2013 | WO2013016427A1 Methods and pharmaceutical compositions for treating celiac disease and gluten intolerance |
| 01/31/2013 | WO2013016220A1 Il-17 receptor a is required for il-17c biology |
| 01/31/2013 | WO2013016197A1 Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as c5a receptor modulators |
| 01/31/2013 | WO2013015152A1 TECHNIQUE FOR CLEAVING OUT PART OF poly(A) CHAIN AND/OR 3'-TERMINAL SEQUENCE OF mRNA TO INHIBIT TRANSLATION REACTION |
| 01/31/2013 | WO2013014691A1 Microvesicles isolated from mesenchymal stem cells for use as immunosuppressive agents |
| 01/31/2013 | WO2013014629A1 Pharmaceutical compositions comprising pyrrole diones and their use to inhibit angiogenesis |
| 01/31/2013 | WO2013014204A2 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 01/31/2013 | WO2013014052A1 Composition |
| 01/31/2013 | WO2013013639A1 Tnf-related apoptosis-inducing ligand fusion protein and preparation and use thereof |
| 01/31/2013 | WO2013013609A1 Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof |
| 01/31/2013 | WO2013013501A1 Traditional chinese medicine composition for enhancing human immune function |
| 01/31/2013 | WO2013013490A1 Use of medicament targeting cyslt1 in preparation of drug for prevention or treatment of autoimmune diseases |
| 01/31/2013 | WO2012143416A3 7 - (3,5 - dimethyl - 4 - isoxazolyl) - 8 - (methyloxy) - 1h - imidazo [4,5 -c] quinoline derivatives |
| 01/31/2013 | WO2012123493A9 Isoxazolidine derivatives |
| 01/31/2013 | WO2012022681A3 Heterocyclyl pyrazolopyrimidine analogues as selective jak inhibitors |
| 01/31/2013 | US20130030014 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS |
| 01/31/2013 | US20130030010 Non-sedating antihistamine injection formulations and methods of use thereof |
| 01/31/2013 | US20130030009 Method for the treatment and/or prevention of oral allergic symptions of the lips due to oral contact with a food allergen |
| 01/31/2013 | US20130030008 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 01/31/2013 | US20130029994 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors |
| 01/31/2013 | US20130029990 Pyrazole p38 map kinase inhibitors |
| 01/31/2013 | US20130029985 Novel Compounds |
| 01/31/2013 | US20130029984 Heterocyclic compounds and uses thereof |
| 01/31/2013 | US20130029982 Heterocyclic compounds and uses thereof |
| 01/31/2013 | US20130029977 Fused substituted aminopyrrolidine derivative |
| 01/31/2013 | US20130029970 CB Receptor Agonists |
| 01/31/2013 | US20130029961 Substituted Heterocyclic Aza Compounds |
| 01/31/2013 | US20130029952 Combination of Azelastine and Mometasone for Nasal Administration |
| 01/31/2013 | US20130029951 Combination of Azelastine and Ciclesonide for Nasal Administration |
| 01/31/2013 | US20130029949 Substituted Quinolines and Their Use As Medicaments |
| 01/31/2013 | US20130029948 Heterocyclic autotaxin inhibitors and uses thereof |
| 01/31/2013 | US20130029944 Inhibitors of protein kinases |
| 01/31/2013 | US20130028993 Composition and Manufacturing Processes of a Toxicity Free Botanical Drug for Curative Treatment of Chronic Diseases |
| 01/31/2013 | US20130028992 Herbal-Based Solution for Treating Symptoms of Nasal Conditions |
| 01/31/2013 | US20130028968 Compositions and methods to relieve chronic diseases symptoms |
| 01/31/2013 | US20130028961 Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators |
| 01/31/2013 | US20130028947 Pharmaceutical composition for topical application |
| 01/31/2013 | US20130028936 Tlr 4 and 9 receptors agonists for preventing septic complications of post-traumatic immunodepression in patients hospitalized for severe traumatic injuries |
| 01/31/2013 | US20130028935 Composition containing hcmv particles |
| 01/31/2013 | US20130028933 Methods for stabilizing influenza antigen enveloped virus-based virus-like particle solutions |
| 01/31/2013 | US20130028932 Compositions comprising polyglutamic acid nanoparticles and polypeptides such as cd40 agonists |
| 01/31/2013 | US20130028931 Novel prrs virus inducing type i interferon in susceptible cells |
| 01/31/2013 | US20130028926 Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells |
| 01/31/2013 | US20130028921 Composition comprising coumestrol or a bean extract containing coumestrol |
| 01/31/2013 | US20130028919 Targeted pyrrolobenzodiazapine conjugates |
| 01/31/2013 | US20130028916 Antagonist anti-il-7 receptor antibodies and methods |
| 01/31/2013 | US20130028901 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 01/31/2013 | US20130028900 Methods and compositions for the generation and use of conformation-specific antibodies |
| 01/31/2013 | US20130028897 Methods for reducing the level of alloantibodies in a subject |
| 01/31/2013 | US20130028894 Methods of treating il-tif associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors |
| 01/31/2013 | US20130028890 Method for detecting regulatory t cells using expression of folate receptor 4 as indicator, method for treating diseases using the detection method, pharmaceutical composition for immunostimulation, and method for treating diseases using the composition |
| 01/31/2013 | US20130028888 Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 01/31/2013 | US20130028887 Phenylacetic acid compound |
| 01/31/2013 | US20130028877 LACTOBACILLUS JOHNSONII La1 NCC533 (CNCM I-1225) AND IMMUNE DISORDERS |
| 01/31/2013 | US20130028876 Thymidine kinase |
| 01/31/2013 | US20130028867 Long-acting interferon beta formulation using immunoglobulin fragment |